These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 21865699

  • 21. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
    Brunasso AM, Puntoni M, Aberer W, Delfino C, Fancelli L, Massone C.
    Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
    [Abstract] [Full Text] [Related]

  • 22. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ, Pariser DM, Yamauchi PS.
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [Abstract] [Full Text] [Related]

  • 23. Focus tonsils and skin diseases with special reference to palmoplantar pustulosis.
    Kuki K, Kimura T, Hayashi Y, Tabata T.
    Adv Otorhinolaryngol; 1992 Apr; 47():196-202. PubMed ID: 1280904
    [No Abstract] [Full Text] [Related]

  • 24. Clinical characteristics of pustulotic arthro-osteitis in Korea.
    Kim M, Kim M, Kim JW, Kim BR, Youn SW.
    J Dermatol; 2022 Aug; 49(8):762-768. PubMed ID: 35510638
    [Abstract] [Full Text] [Related]

  • 25. Immunoglobulin and CD8⁺ T-cell distribution in histologically distinctive tonsils of individuals with tonsillar focal infection.
    Meng HX, Ohe R, Li HN, Yang SR, Kabasawa T, Kato T, Zhang L, Ohtake H, Ishida A, Ohta N, Jin XM, Kakehata S, Yamakawa M.
    Acta Otolaryngol; 2015 Mar; 135(3):264-70. PubMed ID: 25649885
    [Abstract] [Full Text] [Related]

  • 26. Non-bacterial vertebral osteitis as the first manifestation of pustulotic arthro-osteitis.
    Ueda Y, Yokogawa N, Shimada K.
    Mod Rheumatol Case Rep; 2023 Jun 19; 7(2):488-490. PubMed ID: 36905395
    [Abstract] [Full Text] [Related]

  • 27. Exacerbation of pustulosis palmaris et plantaris after topical application of metals accompanied by elevated levels of leukotriene B4 in pustules.
    Nakamura K, Imakado S, Takizawa M, Adachi M, Sugaya M, Wakugawa M, Asahina A, Tamaki K.
    J Am Acad Dermatol; 2000 Jun 19; 42(6):1021-5. PubMed ID: 10827407
    [Abstract] [Full Text] [Related]

  • 28. [Palmoplantar pustulosis].
    Berbis P.
    Rev Prat; 1991 Oct 15; 41(22):2165-8. PubMed ID: 1784916
    [Abstract] [Full Text] [Related]

  • 29. Nail lesions in palmoplantar pustulosis and pustulotic arthro-osteitis impairs patients' quality of life: Suggesting new assessment tool of PPP nail lesions.
    Masuda-Kuroki K, Kawakami H, Abe N, Mori M, Tobita R, Fukushi R, Hiruma J, Takeda Y, Okubo Y.
    J Dermatol Sci; 2022 Apr 15; 106(1):29-36. PubMed ID: 35307234
    [Abstract] [Full Text] [Related]

  • 30. Cefcapene Pivoxil Hydrochloride Is a Potentially New Treatment for Palmoplantar Pustulosis with Pustulotic Arthro-Osteitis.
    Murakami M, Masuda K, Utsunomiya R, Oda F, Namba C, Sayama K.
    Dermatology; 2015 Apr 15; 231(4):304-11. PubMed ID: 26440444
    [Abstract] [Full Text] [Related]

  • 31. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis.
    Hagforsen E, Hedstrand H, Nyberg F, Michaëlsson G.
    Br J Dermatol; 2010 Sep 15; 163(3):572-9. PubMed ID: 20426778
    [Abstract] [Full Text] [Related]

  • 32. Etanercept in the treatment of palmoplantar pustulosis.
    Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, Poulin-Costello CM, Nigen S.
    J Drugs Dermatol; 2008 Oct 15; 7(10):940-6. PubMed ID: 19112757
    [Abstract] [Full Text] [Related]

  • 33. What do we know about palmoplantar pustulosis?
    Misiak-Galazka M, Wolska H, Rudnicka L.
    J Eur Acad Dermatol Venereol; 2017 Jan 15; 31(1):38-44. PubMed ID: 27521275
    [Abstract] [Full Text] [Related]

  • 34. A role of tonsillar lymphocyte for focal infection. With special reference to lymphocyte adhesion to vessels in dermis.
    Akagi Y, Kimura T, Kunimoto M, Kuki K, Tabata T.
    Adv Otorhinolaryngol; 1992 Jan 15; 47():129-33. PubMed ID: 1456121
    [No Abstract] [Full Text] [Related]

  • 35. A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitis.
    Hayama K, Inadomi T, Fujisawa D, Terui T.
    Eur J Dermatol; 2010 Jan 15; 20(6):758-62. PubMed ID: 21047721
    [Abstract] [Full Text] [Related]

  • 36. Clinical manifestations and pathogenesis of tonsillar focal diseases: IgA nephropathy and palmoplantar pustulosis.
    Harabuchi Y.
    Adv Otorhinolaryngol; 2011 Jan 15; 72():1-5. PubMed ID: 21865679
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Animal model of focal tonsillar infection: human tonsillar lymphocytes induce skin lesion in SCID mice.
    Hayashi Y, Kunimoto M, Kuki K, Yamanaka N.
    Acta Otolaryngol Suppl; 1996 Jan 15; 523():193-6. PubMed ID: 9082779
    [Abstract] [Full Text] [Related]

  • 39. Palmoplantar pustulosis and pustulotic arthro-osteitis treatment with potassium iodide and tetracycline, a novel remedy with an old drug: a review of 25 patients.
    Hayashi S, Shimaoka Y, Hamasaki Y, Hatamochi A.
    Int J Dermatol; 2017 Aug 15; 56(8):889-893. PubMed ID: 28369847
    [Abstract] [Full Text] [Related]

  • 40. Histological differentiation between palmoplantar pustulosis and pompholyx.
    Yoon SY, Park HS, Lee JH, Cho S.
    J Eur Acad Dermatol Venereol; 2013 Jul 15; 27(7):889-93. PubMed ID: 22691103
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.